INS and type 1 diabetes mellitus: The subjects with T1D selected for this study used insulin pump-CGM sensor therapy for up to two years, and some of them have lived with diabetes for more than fifty years Tables 1 and 2 summarize the demographic information of the selected subjects and the definition of the variables collected, respectively.